https://www.indianpharmapost.com/zolgensma-used-pre-symptomatically-enables-kids-to-stand-and-walk-115992022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/illumina-welcomes-carissa-rollins-as-chief-information-officer-116152022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/moderna-dosed-the-first-participant-for-an-experimental-hiv-trimer-mrna-vaccine-116142022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-federica-fiorini-is-the-winner-of-the-2022-darlene-solomon-award-116132022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/corbevax-to-be-administered-to-children-between-12-14-years-116122022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/applications-for-pli-in-bulk-drugs-extended-till-march-31st-2022-116112022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-clears-niramais-breast-thermography-device-116102022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/krsnaa-diagnostics-appoints-dr-ravinder-sethi-as-chief-operating-officer-116092022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/illumina-and-trivitron-collaborate-for-next-generation-sequencing-in-india-116082022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/guardant-health-receives-regulatory-approval-for-guardant360-cdx-in-japan-116072022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/clarivate-deals-report-highlights-emerging-trends-in-biopharma-deal-making-116062022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/spag-appoints-ritika-jauhari-as-president-strategy-new-business-116052022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-receives-usfda-tentative-approval-for-hypertension-drug-116042022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-approves-zydus-colestipol-hydrochloride-tablets-116032022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/roche-diagnostics-india-wins-frost-sullivan-2021-india-leadership-award-116022022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/draft-policy-on-medical-devices-released-116012022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/ascletis-increases-ritonavir-production-capacity-to-530-million-tablets-a-year-116002022-03-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/adlarity-receives-usfda-approval-for-treatment-of-alzheimer-116162022-03-14T00:00:00+05:30always0.9